Skip to main content

Table 3 Information of sample collection and prevalence of k13 mutation and pm2 with multi-copies in all the samples

From: No evidence of amplified Plasmodium falciparum plasmepsin II gene copy number in an area with artemisinin-resistant malaria along the China–Myanmar border

Sample collection

Year

Site

k13

pm2

No. of tested

No. of mutant

% of mutant

No. of tested

No. of k13 wild-type

No. of k13 mutant

Single copy

Multi-copies (> 1.6)

% Of multi-copies

TES

2010

Yingjiang

26

16

61.5%

20

10

10

20

0

0.0%

2012

Tengchong

12

10

83.3%

10

1

9

10

0

0.0%

2012

Yingjiang

25

9

36.0%

20

16

4

20

0

0.0%

2013

Yingjiang

20

11

55.0%

19

9

10

19

0

0.0%

2013

Ruili

6

0

0.0%

6

6

0

6

0

0.0%

2014

Menglian

10

0

0.0%

10

10

0

10

0

0.0%

  

Sub total

99

46

46.5%

85

52

33

85

0

0.0%

Passive detection

2011

Menglian County hospital

8

0

0.0%

 

2011

Tengchong (Wuhe hospital)

125

49

39.0%

105

68

37

105

0

0.0%

2012

Yingjiang (Nabang Hospital)

4

2

50.0%

3

2

1

3

0

0.0%

2013

Tengchong County hospital

6

4

66. 7%

6

2

4

6

0

0.0%

2013

Yingjiang (Nabang Hospital)

12

11

91.7%

12

1

11

11

1a

9.1%

2014

Yingjiang (Nabang Hospital)

14

6

42.9%

13

8

5

13

0

0.0%

  

Sub total

169

72

42.6%

139

81

58

138

11

9.1%

Total

  

268

118

44.0%

224

133

91

223

1

0.4%

  1. aThe only one sample with multi-copies of pm2 was carrying k13 mutant